| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 32.866 | 37.494 | 39.789 | 46.515 | 54.966 | 49.684 | 43.820 | 53.326 | 66.834 | 91.842 |
| Total Income - EUR | 32.983 | 37.543 | 39.799 | 46.520 | 54.972 | 52.792 | 43.825 | 66.716 | 66.841 | 91.852 |
| Total Expenses - EUR | 15.292 | 21.880 | 34.941 | 37.025 | 34.635 | 37.494 | 33.930 | 47.736 | 32.401 | 36.657 |
| Gross Profit/Loss - EUR | 17.691 | 15.663 | 4.858 | 9.495 | 20.337 | 15.299 | 9.894 | 18.980 | 34.440 | 55.195 |
| Net Profit/Loss - EUR | 15.976 | 15.288 | 4.460 | 9.030 | 19.788 | 14.838 | 9.456 | 18.313 | 33.771 | 52.440 |
| Employees | 2 | 2 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
Check the financial reports for the company - Usurelu Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 30.112 | 29.227 | 19.915 | 18.056 | 17.136 | 16.250 | 15.342 | 0 | 0 | 844 |
| Current Assets | 25.800 | 25.902 | 20.416 | 21.072 | 22.164 | 32.553 | 18.215 | 32.461 | 44.544 | 68.319 |
| Inventories | 683 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 12.343 | 7.581 | 7.331 | 4.612 | 4.879 | 1.578 | 862 | 12.995 | 4.880 | 49.569 |
| Cash | 12.774 | 18.321 | 13.085 | 16.461 | 17.285 | 30.975 | 17.352 | 19.466 | 39.664 | 18.750 |
| Shareholders Funds | 46.784 | 16.059 | 5.219 | 9.264 | 28.872 | 43.163 | 15.845 | 18.362 | 39.867 | 52.488 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.128 | 39.070 | 35.112 | 29.865 | 10.427 | 5.640 | 17.712 | 14.099 | 4.677 | 16.675 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Usurelu Med Srl